Page last updated: 2024-09-03

ro 8-0576 and Acute Disease

ro 8-0576 has been researched along with Acute Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, SY; Ng, RX; Tan, AH1
Prevett, MC; Rossor, MN1
Koller, WC; Lang, AE; Marsden, CD; Quinn, NP1

Other Studies

3 other study(ies) available for ro 8-0576 and Acute Disease

ArticleYear
Osmotic Demyelination Syndrome With Evolving Movement Disorders.
    JAMA neurology, 2018, 07-01, Volume: 75, Issue:7

    Topics: Acute Disease; Adult; Akinetic Mutism; Athetosis; Benserazide; Chorea; Demyelinating Diseases; Dopamine Agents; Drug Combinations; Fluid Therapy; Gastroenteritis; Humans; Hyponatremia; Levodopa; Male; Myelinolysis, Central Pontine; Parkinsonian Disorders; Saline Solution; Time Factors

2018
Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3

    Topics: Acute Disease; Adult; Antiparkinson Agents; Benserazide; Cystic Fibrosis; Drug Combinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Myelinolysis, Central Pontine; Parkinson Disease, Secondary; Pons

1999
Painful Parkinson's disease.
    Lancet (London, England), 1986, Jun-14, Volume: 1, Issue:8494

    Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pain; Parkinson Disease; Time Factors

1986